Produced in rabbits immunized with E. coli-derived Human ERCC5 fragment, and purified by antigen affinity chromatography.
Source
Polyclonal Rabbit IgG
Purification
Protein A & Antigen Affinity
Formulation
PBS, pH7.0 with 0.03% Proclin300
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Avoid repeated freeze-thaw cycles.
Immunofluorescence staining of ERCC5 in U251MG cells. Cells were fixed with 4% PFA, permeabilzed with 0.1% Triton X-100 in PBS,blocked with 10% serum, and incubated with rabbit anti-Human ERCC5 polyclonal antibody (dilution ratio 1:200) at 4℃ overnight. Then cells were stained with the Alexa Fluor®488-conjugated Goat Anti-rabbit IgG secondary antibody (green). Positive staining was localized to Nucleus.
Excision repair cross-complementation group 5 (ERCC5) gene plays an important role in nucleotide excision repair, and dysregulation of ERCC5 is associated with increased lung cancer risk. Excision repair cross-complementing group 5 (ERCC5 or XPG) plays an important role in regulating DNA excision repair, removal of bulky lesions caused by environmental chemicals or UV light. Mutations in this gene cause a rare autosomal recessive syndrome, and its functional single nucleotide polymorphisms (SNPs) may alter DNA repair capacity and thus contribute to cancer risk. The excision repair cross-complementation group 5 (ERCC5) gene is a central component of NER. Ectopic expression of ERCC5 has been linked to different types of cancers, including hepatocellular carcinoma (HCC). Single nucleotide polymorphism in ERCC5 was responsible for different cancers.
References
Zhu ML, et al. (2012) Association between the ercc5 asp1104his polymorphism and cancer risk: A meta-analysis. PLoS One 7 (7): e36293.
Zheng X, et al. (2018) High expression of ercc5 predicts a poor prognosis in hepatocellular carcinoma. Int J Clin Exp Pathol 11 (7): 3664-3670.
Zhang X, et al. (2016) Haplotype and diplotype analyses of variation in ercc5 transcription cis-regulation in normal bronchial epithelial cells. Physiol Genomics 48 (7): 537-543.
Shakil Malik S, et al. (2019) Genetic polymorphism in ercc5 and breast cancer risk. Mol Biol Res Commun 8 (1): 27-31.